These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10558537)

  • 41. Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Jul; 82(134):32457-61. PubMed ID: 28715162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Aug; 67(154):51987-52007. PubMed ID: 12194173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of drug codes for 26 substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2013 Jan; 78(3):664-6. PubMed ID: 23289157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2009 May; 74(97):23789-90. PubMed ID: 19507328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schedules of controlled substances; exempt anabolic steroid products. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Mar; 73(52):14178-9. PubMed ID: 18464343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 58. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2012 Oct; 77(202):64032-3. PubMed ID: 23077760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.